Loading...
Loading...
Loading...
Loading...
Try browsing our complete catalog of products.
No reviews have been added for this product.
Atlas Antibodies
Atlas Antibodies
![Lane 1: Marker [kDa] 230, 130, 95, 72, 56, 36, 28, 17, 11<br/>Lane 2: Human cell line RT-4<br/>Lane 3: Human cell line U-251MG sp<br/>Lane 4: Human plasma (IgG/HSA depleted)<br/>Lane 5: Human liver tissue](https://cdn11.bigcommerce.com/s-nqdal6gcku/images/stencil/3840w/products/43853/22558/atl-hpa015066_anti-cyp2c9-pab-atl-hpa015066_33267__34960.1783626317.jpg?compression=lossy)
| Product Specifications | |
| Application | WB, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | KEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTST |
| Gene Sequence | KEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTST |
| Gene ID - Mouse | ENSMUSG00000067231 |
| Gene ID - Rat | ENSRNOG00000052810 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti CYP2C9 pAb (ATL-HPA015066) | |
| Datasheet | Anti CYP2C9 pAb (ATL-HPA015066) Datasheet (External Link) |
| Vendor Page | Anti CYP2C9 pAb (ATL-HPA015066) at Atlas Antibodies |
| Documents & Links for Anti CYP2C9 pAb (ATL-HPA015066) | |
| Datasheet | Anti CYP2C9 pAb (ATL-HPA015066) Datasheet (External Link) |
| Vendor Page | Anti CYP2C9 pAb (ATL-HPA015066) |
| Citations for Anti CYP2C9 pAb (ATL-HPA015066) – 2 Found |
| Ashida, Ryo; Okamura, Yukiyasu; Ohshima, Keiichi; Kakuda, Yuko; Uesaka, Katsuhiko; Sugiura, Teiichi; Ito, Takaaki; Yamamoto, Yusuke; Sugino, Takashi; Urakami, Kenichi; Kusuhara, Masatoshi; Yamaguchi, Ken. The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma. Oncotarget. 2018;9(31):22058-22068. PubMed |
| Uehara, Shotaro; Iida, Yuichi; Ida-Tanaka, Miyuki; Goto, Motohito; Kawai, Kenji; Yamamoto, Masafumi; Higuchi, Yuichiro; Ito, Satoshi; Takahashi, Riichi; Kamimura, Hidetaka; Ito, Mamoru; Yamazaki, Hiroshi; Oshimura, Mitsuo; Kazuki, Yasuhiro; Suemizu, Hiroshi. Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism. Scientific Reports. 2022;12(1):14907. PubMed |
| Product Specifications | |
| Application | WB, IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | KEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTST |
| Gene Sequence | KEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTST |
| Gene ID - Mouse | ENSMUSG00000067231 |
| Gene ID - Rat | ENSRNOG00000052810 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti CYP2C9 pAb (ATL-HPA015066) | |
| Datasheet | Anti CYP2C9 pAb (ATL-HPA015066) Datasheet (External Link) |
| Vendor Page | Anti CYP2C9 pAb (ATL-HPA015066) at Atlas Antibodies |
| Documents & Links for Anti CYP2C9 pAb (ATL-HPA015066) | |
| Datasheet | Anti CYP2C9 pAb (ATL-HPA015066) Datasheet (External Link) |
| Vendor Page | Anti CYP2C9 pAb (ATL-HPA015066) |
| Citations for Anti CYP2C9 pAb (ATL-HPA015066) – 2 Found |
| Ashida, Ryo; Okamura, Yukiyasu; Ohshima, Keiichi; Kakuda, Yuko; Uesaka, Katsuhiko; Sugiura, Teiichi; Ito, Takaaki; Yamamoto, Yusuke; Sugino, Takashi; Urakami, Kenichi; Kusuhara, Masatoshi; Yamaguchi, Ken. The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma. Oncotarget. 2018;9(31):22058-22068. PubMed |
| Uehara, Shotaro; Iida, Yuichi; Ida-Tanaka, Miyuki; Goto, Motohito; Kawai, Kenji; Yamamoto, Masafumi; Higuchi, Yuichiro; Ito, Satoshi; Takahashi, Riichi; Kamimura, Hidetaka; Ito, Mamoru; Yamazaki, Hiroshi; Oshimura, Mitsuo; Kazuki, Yasuhiro; Suemizu, Hiroshi. Humanized liver TK-NOG mice with functional deletion of hepatic murine cytochrome P450s as a model for studying human drug metabolism. Scientific Reports. 2022;12(1):14907. PubMed |